Head-to-head · WeighScore
FMmeds vs Ravia Health
The verdict
FMmeds takes it — 63.2/100 to 59.2/100.
FMmeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FMmeds is a Manhattan Beach-based DTC telehealth platform selling compounded semaglutide and tirzepatide co-formulated with vitamin B12, with no membership fee and a free initial visit billed only on approval.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | FMmeds | Ravia Health |
|---|---|---|
| WeighScore | 63.2/100 | 59.2/100 |
| Grade | C | C |
| Scorecard rank | #257 | #347 |
| Semaglutide | $225/mo (all doses, compounded) | Not disclosed |
| Tirzepatide | $265/mo (all doses, compounded) | Not disclosed |
| Coverage | All 50 states | 1 state |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #257 · C
Strengths
- All 50 states plus DC covered, stated in the Terms
- Operating LLC and full Manhattan Beach, CA address disclosed
- Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
- Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
- Flat pricing across all dose strengths — no dose-escalation surcharge
Where it loses points
- Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
- Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
- Clinical network not separately named
- LegitScript Certified, but the specific ID isn't shown
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Graded #347 · C
Strengths
- Integrative psychiatry model combines GLP-1 weight-loss with mental health and metabolic care under one board-certified NP provider
- Founded by Dr. Raashida Portier (DNP, PMHNP-BC, FNP-BC); named clinician with dual board certifications in psychiatry and family medicine
- Membership-supported ongoing care from $49/month provides medication management structure with consistent follow-up
- Labs and metabolic workup available as part of integrative psychiatry model; lab testing noted in weight-loss program
- Weight-loss page claims nationwide availability via Lyv Health partnership for eligible patients
Where it loses points
- GLP-1 medication pricing fully gated — not disclosed until consultation; compounded vs. brand status unclear on public pages
- Primarily a psychiatric practice — weight loss is a secondary service, not the core offering or brand identity
- Core services explicitly Florida-only; nationwide weight-loss claim relies on Lyv Health partnership with unverified state coverage
- No LegitScript certification or third-party accreditation found on public pages
- Small single-provider practice with no published outcomes data or external reviews available
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.